TY - JOUR T1 - Patterns of IgM Binding to Tumor Associated Antigen Peptides Correlate with the Type of Brain Tumors JF - medRxiv DO - 10.1101/2020.06.19.20135509 SP - 2020.06.19.20135509 AU - Dilyan Ferdinandov AU - Viktor Kostov AU - Maya Hadjieva AU - Velizar Shivarov AU - Assen Bussarsky AU - Anastas Pashov Y1 - 2020/01/01 UR - http://medrxiv.org/content/early/2020/06/20/2020.06.19.20135509.abstract N2 - The immune system can be used as a biosensor of the internal environment. Changes in the reactivities of the antibody repertoire can be used as a readout for a wide range of disturbances including various inflammatory conditions and malignant tumors. Extending our previous work based on IgM mimotope libraries, here we report our studies on the interpretability of profiles of IgM reactivities to a library of natural 15-mer peptides derived from 20 tumor associated antigens and 193 linear B cell epitopes involved in tumor pathogenesis. Sera from 21 patients with glioblastoma multiforme (GBM, n=10), brain metastases of other tumors (n=5) and non-tumor bearing neurosurgery patients (n=6) were used to probe their IgM reactivity with an array of 4526 peptide sequences. Using feature selection algorithms, we were able to extract profiles that separated well the three diagnostic groups with accuracy of up to 0.9. A key feature of the profiles extracted was their size (138 peptides for differentiating GBM and 340 – for tumor bearing patients) and origin from practically all tested antigens. Comparable numbers of reactivities were gained or lost in tumor bearing patients. A minimal set of the most significant 41 reactivities from 16 antigens contained disproportionately large number of epitopes from stromelysine-3 and erbB2 receptor with some of the reactivities gained and other lost in cancer patients. Epitopes from human papilloma virus 16 and HTLV-1 were included too. Some of the reactivities were readily interpretable both as antigen source and structural context (signal peptides). The interpretation of the rest requires further confirmatory studies. Thus, a set of natural peptides from tumor antigens readily provides profile of interpretable IgM reactivities which can serve as classifiers for clinically relevant patient stratification.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was performed with the support of intramural grant of the Medical University in Sofia 355/2015 and the Bulgarian Fund for Scientific Research Grant D01-11/2016.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:All blood serum and brain tumor samples were obtained and analyzed after signed informed consent approved by the Ethics Committee at Medical University, Sofia.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data and scripts are available from GitHub. https://github.com/ansts/TAAIgM ER -